£520.00

It has never been this cheap. We have no record of a lower price.

£520 today · cheaper than every other day in the last 3 months

Hormone Therapy for Prostate Cancer Outlook 2023-2028

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 87 days · 87 data points (no recent data)

Historical
Generating forecast…
£520.00 £494.00 £504.40 £514.80 £525.20 £535.60 £546.00 11 August 2026 01 September 2026 23 September 2026 14 October 2026 05 November 2026
View at Amazon ↗

Price data checked 4 days ago

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 87 days • 1 price levels

Days at Price
87 days 0 22 44 65 87 £520 Days at Price

Price Analysis

Most common price: £520 (87 days, 100.0%)

Price range: £520 - £520

Price levels: 1 different prices over 87 days

Description

This comprehensive study provides a detailed outlook for hormone therapy for prostate cancer therapeutics in the United States from 2023 to 2028. It focuses on latent demand, offering potential industry earnings (P.I.E.) estimates across approximately 12,600 cities. By analyzing data at the state and city levels, this report identifies the percent share each location holds relative to its state and the nation. These comparative benchmarks allow professionals to gauge specific city performance against others. This statistical approach provides a foundation for developing effective distribution and sales force strategies within the United States market.

Key Features

Provides latent demand outlooks for hormone therapy for prostate cancer therapeutics through 2028.

Includes potential industry earnings (P.I.E.) estimates for approximately 12,600 cities across the United States.

Reports the percent share of each city relative to its state and the total United States market.

Offers comparative benchmarks to help users gauge city performance against other locations.

Supports the development of distribution and sales force strategies through detailed statistical data.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
26 October 2022
Listed Since
10 November 2022

Similar Products You Might Like

World Outlook: Hormone Therapy for Prostate Cancer 2025-2030
99% match

World Outlook: Hormone Therapy for Prostate Cancer 2025-2030

Price unavailable
Hormone Therapy for Prostate Cancer Outlook 2023-2028
98% match

Hormone Therapy for Prostate Cancer Outlook 2023-2028

£490.00 05 Nov 2026
Prostate Cancer Therapeutics Outlook in Japan (2016-2021)
98% match

Prostate Cancer Therapeutics Outlook in Japan (2016-2021)

£595.00 23 Sep 2026
Prostate Cancer Therapeutics in Africa 2013-2018 Outlook
97% match

Prostate Cancer Therapeutics in Africa 2013-2018 Outlook

£325.00 03 Sep 2026
Hormone Replacement Therapies in India 2023-2028 Outlook
97% match

Hormone Replacement Therapies in India 2023-2028 Outlook

£515.00 06 Nov 2026
World Outlook for Prostate Cancer Treatments 2025-2030
97% match

World Outlook for Prostate Cancer Treatments 2025-2030

Price unavailable
World Outlook for Prostate Cancer Treatments 2025-2030
97% match

World Outlook for Prostate Cancer Treatments 2025-2030

Price unavailable
Uterine Cancer Therapeutics and Diagnostics Outlook 2023-2028
96% match

Uterine Cancer Therapeutics and Diagnostics Outlook 2023-2028

£520.00 06 Nov 2026
Testosterone Replacement Therapy Outlook in India 2023-2028
96% match

Testosterone Replacement Therapy Outlook in India 2023-2028

£515.00 06 Nov 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States
96% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States

£520.00 30 Sep 2026
US Cancer Supportive Care Outlook 2023-2028 Study Report
96% match

US Cancer Supportive Care Outlook 2023-2028 Study Report

£520.00 07 Nov 2026
Uterine Cancer Therapeutics and Diagnostics in India Outlook
96% match

Uterine Cancer Therapeutics and Diagnostics in India Outlook

£515.00 05 Nov 2026
Healthcare Provider Network Management in India 2023-2028
96% match

Healthcare Provider Network Management in India 2023-2028

£515.00 02 Sep 2026
World Outlook 2025-2030: Testosterone Replacement Therapy
96% match

World Outlook 2025-2030: Testosterone Replacement Therapy

£790.00 25 Aug 2026
Non-Hodgkin Lymphoma Chemotherapy Outlook 2023-2028 Study
96% match

Non-Hodgkin Lymphoma Chemotherapy Outlook 2023-2028 Study

£520.00 07 Nov 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in India
96% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in India

£515.00 30 Sep 2026
2023-2028 US Cancer Screening Outlook - Market Study
96% match

2023-2028 US Cancer Screening Outlook - Market Study

£520.00 05 Nov 2026
Non-Hodgkin Lymphoma Chemotherapy Outlook in India 2023-2028
96% match

Non-Hodgkin Lymphoma Chemotherapy Outlook in India 2023-2028

£515.00 07 Nov 2026
US Corticoids and Hormone Pharmaceuticals Outlook 2016-2021
96% match

US Corticoids and Hormone Pharmaceuticals Outlook 2016-2021

£595.00 05 Sep 2026
US Hematology and Oncology Products Market Outlook 2016-2021
96% match

US Hematology and Oncology Products Market Outlook 2016-2021

£595.00 18 Sep 2026
The 2016-2021 Outlook for Local and Topical Corticoids, Hormones, and Synthetic Hormone Substitute Pharmaceuticals in Greater China
96% match

The 2016-2021 Outlook for Local and Topical Corticoids, Hormones, and Synthetic Hormone Substitute Pharmaceuticals in Greater China

£595.00 02 Sep 2026